Microprofit Biotech

Microprofit
Biotech

You are here: Home >> News >> Company News >> fluorecare COVID-19 Antigen Test Kit is approved in Switzerland

You are here: Home >> News >> Company News

fluorecare COVID-19 Antigen Test Kit is approved in Switzerland

We are glad to announce that in 12. December 2020 Technical validation report Rapid COVID-19 Antigen test of fluorecare SARS-CoV-2 Spike Protein Test Kit is received and The fluorecare Test Kit has passed the validation criteria as described by the Swiss Society of Microbiology.
At Ct-values of 23, 26 and 29, the fluorecare Test Kit assay showed a technical sensitivity of 100%, 95.8% and 92.5% compared to a reference standard showing a technical sensitivity of 98.1%, 97.2% and 92.5%, respectively. The technical specificity was 100%.
Please contact us without hesitate when you are interesting about the detail information of the technical validation report.

fluorecare COVID-19 Antigen Test Kit is approved in Switzerland

We are glad to announce that in 12. December 2020 Technical validation report Rapid COVID-19 Antigen test of fluorecare SARS-CoV-2 Spike Protein Test Kit is received and The fluorecare Test Kit has passed the validation criteria as described by the Swiss Society of Microbiology.
At Ct-values of 23, 26 and 29, the fluorecare Test Kit assay showed a technical sensitivity of 100%, 95.8% and 92.5% compared to a reference standard showing a technical sensitivity of 98.1%, 97.2% and 92.5%, respectively. The technical specificity was 100%.
Please contact us without hesitate when you are interesting about the detail information of the technical validation report.

© 2019 Microprofit Biotech